NCT04005586View on ClinicalTrials.gov

A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
AphakiaCataract
Interventions
DEVICE

Light Delivery Device (LDD)

Study eye will undergo Light delivery Device treatments

Trial Locations (2)

44141

Cleveland Eye Clinic, Brecksville

57108

Vance Thompson Vision Clinic, Sioux Falls

All Listed Sponsors
lead

RxSight, Inc.

INDUSTRY

NCT04005586 - A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL) | Biotech Hunter | Biotech Hunter